You are here

Home » Content

No-Reflfl ow Fenomeni: Hikayenin Sonu mu?

No-Refl ow Phenomenon: Is it the End of the Story?

Journal Name:

  • Akdeniz Tıp Dergisi

Publication Year:

  • 2015

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Ineffi cient myocardial perfusion in spite of successful accomplishment of epicardial coronary artery patency is referred to as the no-refl ow phenomenon. No-refl ow occurrence during the progression of acute myocardial infarction worsens the prognosis. There are many defi nitions of no-refl ow depending on the diagnostic imaging modality. Intracoronary drug administration, manual thrombus aspiration and avoiding strategies that cause endothelial injury are the main principles of no-refl ow treatment. Prevention in patients with clinical and angiographic high risk factors seems to be the mainstay strategy instead of using the present treatment options.
Bookmark/Search this post with
Abstract (Original Language): 
Epikardiyal koroner arterde açıklığın elde edilmesine rağmen miyokard perfüzyonunun yeterli düzeyde sağlanamaması durumu no-Refl ow Fenomeni olarak isimlendirilmektedir. Akut miyokard infarktüsü sırasında gelişen no-refl ow prognozu olumsuz yönde etkilemektedir. Kullanılan tanısal görüntüleme yöntemlerine bağlı olarak farklı tanımlamaları mevcuttur. İntrakoroner uygulanan farmakolojik ajanlar, manuel trombüs aspirasyonu ve anjiyoplasti sırasında endotel hasarını arttıracak stratejilerden kaçınılması tedavinin temel prensiplerini oluşturmaktadır. Etkin tedavisinin olmaması nedeniyle klinik ve anjiyografi k risk faktörleri olan hastalarda no-refl ow gelişimini önlemeye yönelik stratejilerin uygulanması en önemli tedavi yaklaşımı olmayı sürdürmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-no-reflfl-ow-fenomeni-hikayenin-sonu-mu.pdf
  • 2
89
93
  • Turkish

REFERENCES

References: 

1. Keeley EC, Boura JA, Grines Cl. Primary angioplasty
versus intravenous thrombolytic therapy for acute
myocardial infarction: A quantitative review of 23
randomised trials. Lancet 2003;361:13–20.
2. Krug A, DuMesnil de Rochemont W, Korb G. Blood
supply of the myocardium after temporary coronary
occlusion. Circ Res 1966;19:57–62.
3. Kloner RA, Ganote CE, Jenning RB. The “no-refl ow”
phenomenon after temporary coronary occlusion in the
dog. J Clin Invest 1974;54:1496–508.
4. Durante A, Camici PG. Novel insights into an “old”
phenomenon: the no refl ow. Int J Cardiol 2015;187:273–80
5. Tranum-Jensen J, Janse MJ, Fiolet WT, Krieger WJ,
D’Alnoncourt CN, Durrer D. Tissue osmolality, cell
swelling, and reperfusion in acute regional myocardial
ischemia in the isolated porcine. Circ Res 1981;49:364–81.
6. Reffelmann T, Kloner RA. The no-refl ow phenomenon: A
basic mechanism of myocardial ischemia and reperfusion.
Basic Res Cardiol 2006;101:359 –72.
7. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK,
Roberts R, McCay PB. Direct evidence that oxygenderived
free radicals contribute to postischemic myocardial
dysfunction in the intact dog. Proc Natl Acad Sci USA
1989; 86: 4695-99.
8. Ambrosio G, Tritto I. Reperfusion injury: Experimental
evidence and clinical implications. Am Heart J 1999;138:
S69 –75.
93
No-Refl ow Fenomeni: Hikayenin Sonu mu?
Akd Tıp D / Akd Med J / 2015; 2: 89-93
9. Skyschally A, Leineweber K, Gres P, Haude M, Erbel
R, Heusch G. Coronary microembolization. Basic Res
Cardiol 2006;101:373– 82.
10. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial No-
Refl ow in humans. J Am Coll Cardiol 2009;54:281–92.
11. Yip HK, Chen MC, Chang HW, et al. Angiographic
morphologic features of infarct-related arteries and timely
reperfusion in acute myocardial infarction: Predictors
of slow-fl ow and no-refl ow phenomenon. Chest
2002;122:1322–32.
12. The TIMI Study Group. The thrombolysis in myocardial
infarction [TIMI] trial. Phase I fi ndings. N Engl J Med
1985;312:932– 6.
13. van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC,
de Boer MJ, Zijlstra F; Zwolle Myocardial Infarction
Study Group. Angiographic assessment of myocardial
reperfusion in patients treated with primary angioplasty
for acute myocardial infarction: Myocardial blush grade.
Circulation 1998;97:2302– 6.
14. Schröder R. Prognostic impact of early ST-segment
resolution in acute ST-elevation myocardial infarction.
Circulation 2004;110:e506 –10.
15. Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L,
Rizzon P. Myocardial contrast echocardiography in acute
myocardial infarction. Pathophysiological background
and clinical applications. Eur Heart J 1996;17:344 –53.
16. Albert TS, Kim RJ, Judd RM. Assessment of norefl
ow regions using cardiac MRI. Basic Res Cardiol
2006;101:383–90.
17. Petronio AS, De Carlo M, Ciabatti N, et al. Left ventricular
remodeling after primary coronary angioplasty in patients
treated with abciximab or intracoronary adenosine. Am
Heart J 2005;150: 1015.
18. Danzi GB, Sesana M, Capuano C, Mauri L, Berra
Centurini P, Baglini R. Comparison in patients having
primary coronary angioplasty of abciximab versus
tirofi ban on recovery of left ventricular function. Am J
Cardiol 2004;94:35–9.
19. Young JJ, Cox DA, Stuckey T, et al. Prospective,
multicenter study of thrombectomy in patients with acute
myocardial infarction: The X-Tract AMI registry. J Interv
Cardiol 2007;20:44 –50.
20. Burzotta F, Trani C, Romagnoli E, et al. Manual
thrombus aspiration improves myocardial reperfusion:
The randomized evaluation of the effect of mechanical
reduction of distal embolization by thrombus-aspiration
in primary and rescue angioplasty (REMEDIA) trial. J
Am Coll Cardiol 2005;46:371– 6.
21. Marzilli M, Orsini E, Marraccini P, Testa R. Benefi cial
effects of intracoronary adenosine as an adjunct to
primary angioplasty in acute myocardial infarction.
Circulation 2000;101:2154 –9.
22. Taniyama Y, Ito H, Iwakura K, et al. Benefi cial effect of
intracoronary verapamil on microvascular and myocardial
salvage in patients with acute myocardial infarction. J Am
Coll Cardiol 1997;30:1193–9.
23. Amit G, Cafri C, Yaroslavtsev S, et al. Intracoronary
nitroprusside for the prevention of the no-refl ow
phenomenon after primary percutaneous coronary
intervention in acute myocardial infarction. A randomized,
double-blind, placebo-controlled clinical trial. Am Heart J
2006;152:887,e9 –14.
24. Ito H, Taniyama Y, Iwakura K, et al. Intravenous
nicorandil can preserve microvascular integrity
and myocardial viability in patients with reperfused
anterior wall myocardial infarction. J Am Coll Cardiol
1999;33:654–60.
25. Burzotta F, Testa L, Giannico F, et al. Adjunctive devices
in primary or rescue PCI: A meta-analysis of randomized
trials. Int J Cardiol 2008;123:313–21.
26. Azzalini L, Millán X, Ly HQ, L’allier PL, Jolicoeur
EM. Direct stenting versus pre-dilation in ST-elevation
myocardial infarction: A systematic review and metaanalysis.
J Interven Cardiol 2015;28:119–31.

Thank you for copying data from http://www.arastirmax.com